Leveraging Biologics: Treatment Advances in the Management of Childhood-Onset Systemic Lupus Erythematosus

NOTE: This session is part of the Live Intensive Studies and Clinical Sessions packages. All attendees may attend these thought-provoking and highly educational sessions. However, if you are board-certified, you must purchase the package(s) for your specialty to receive the recertification assessment and claim the recertification credit.

Treatment of childhood-onset systemic lupus erythematosus (cSLE) has been limited to traditional immunomodulators until the recent introduction of biologic therapy. Knowledge of these agents and their role in treatment is necessary for the pediatric pharmacist to develop an effective and safe therapeutic regimen and monitoring plan. This session will focus on the role of biologic therapy in the management of cSLE using interactive patient cases and an in-depth evaluation of the current literature in order to equip the pediatric pharmacist with the necessary knowledge and tools to integrate into clinical practice.

This activity is approved for Board-Certified Pediatric Pharmacist (BCPPS) recertification credit.